As of 2025-10-21, the EV/EBITDA ratio of Editas Medicine Inc (EDIT) is -2.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EDIT's latest enterprise value is 372.27 mil USD. EDIT's TTM EBITDA according to its financial statements is -156.26 mil USD. Dividing these 2 quantities gives us the above EDIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 15.5x | 14.8x |
| Forward P/E multiples | 15.0x - 16.5x | 15.8x |
| Fair Price | (26.10) - (27.00) | (26.54) |
| Upside | -730.5% - -752.3% | -741.2% |
| Date | EV/EBITDA |